Baker & Eastlack Ventures
Baker & Eastlack Ventures
  • Home
  • About
  • Portfolio
  • Investment Focus
  • News
  • Contact
October 31 2019

With smartphone-connected home light therapy, Clarify Medical breaks new ground in psoriasis

The company which recently raised $18 million, has a connected device that is approved for Medicare coverage of psoriasis, while its smartphone app offers opportunities for engaging patients beyond treatment.

A San Diego-based medical-device maker has landed a Series A investment of $18 million that will help to further commercialize its connected, handheld phototherapy device that is FDA-approved for patients with psoriasis and other skin conditions.

Read the entire article here: https://medcitynews.com/2019/10/with-smartphone-connected-home-light-therapy-clarify-medical-breaks-new-ground-in-psoriasis

 

ControlRadâ„¢ Secures $15 Million Series B Financing, Expands Board of Directors StimGuard appoints new chief financial officer

Related Posts

Uncategorized

Micron Medical Appoints Seasoned Healthcare Executive Mark Landy as Chief Executive Officer

Uncategorized

Zerigo Now Approved as a MultiPlan Participating Provider

Uncategorized

Spinal Singularity Hires New CEO

Baker & Eastlack Ventures

Contact Us

Email: bakerandeastlack@gmail.com

© Baker & Eastlack Ventures 2023